Antidepressant Medication Use in Pregnancy

被引：9
作者：
Hackley, Barbara [1 ,2 ]
机构：
[1] Montefiore S Bronx Hlth Ctr Children & Families, Womens Hlth Serv, Bronx, NY 10459 USA
[2] Yale Univ, Sch Nursing, New Haven, CT 06536 USA
来源：
JOURNAL OF MIDWIFERY & WOMENS HEALTH | 2010年 / 55卷 / 02期
关键词：
antidepressant medication; depression; pregnancy; SSRI; SEROTONIN-REUPTAKE INHIBITORS; PERSISTENT PULMONARY-HYPERTENSION; MATERNAL DEPRESSION; MAJOR DEPRESSION; PSYCHOSOCIAL STRESS; PRENATAL EXPOSURE; IN-UTERO; RISK; WOMEN; MOOD;
D O I：
10.1016/j.jmwh.2009.11.003
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Depression has been estimated to occur in approximately 12% of women, making it one of the most commonly encountered medical conditions affecting pregnancy. Yet many health care providers feel unprepared to manage this condition in pregnancy. This article provides women's health providers the background needed to effectively manage depression and in particular focuses on the use of antidepressant medication in pregnancy. J Midwifery Womens Health 2010; 55: 90-100 (C) 2010 by the American College of Nurse-Midwives.
引用
收藏
页码：90 / 100
页数：11
相关论文
共 50 条
  • [41] Antidepressant use in pregnancy: a critical review focused on risks and controversies
    Byatt, N.
    Deligiannidis, K. M.
    Freeman, M. P.
    ACTA PSYCHIATRICA SCANDINAVICA, 2013, 127 (02) : 94 - 114
  • [42] Antidepressant Use in Pregnancy: An Evaluation of Adverse Outcomes Excluding Malformations
    Lorenzo, Laura
    Einarson, Adrienne
    ISRAEL JOURNAL OF PSYCHIATRY AND RELATED SCIENCES, 2014, 51 (02) : 94 - 105
  • [43] Decision-making about antidepressant medication use in pregnancy: a comparison between women making the decision in the preconception period versus in pregnancy
    Barker, Lucy C.
    Dennis, Cindy-Lee
    Hussain-Shamsy, Neesha
    Stewart, Donna E.
    Grigoriadis, Sophie
    Metcalfe, Kelly
    Oberlander, Tim F.
    Schram, Carrie
    Taylor, Valerie H.
    Vigod, Simone N.
    BMC PSYCHIATRY, 2020, 20 (01)
  • [44] Methodological considerations in assessing the effectiveness of antidepressant medication continuation during pregnancy using administrative data
    Swanson, Sonja A.
    Hernandez-Diaz, Sonia
    Palmsten, Kristin
    Mogun, Helen
    Olfson, Mark
    Huybrechts, Krista F.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (09) : 934 - 942
  • [45] Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication
    Lewis, Andrew J.
    Galbally, Megan
    Opie, Gillian
    Buist, Anne
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2010, 44 (05) : 482 - 487
  • [46] Prenatal exposure to antidepressant medications and neurodevelopmental outcomes: A systematic review
    Gentile, Salvatore
    Galbally, Megan
    JOURNAL OF AFFECTIVE DISORDERS, 2011, 128 (1-2) : 1 - 9
  • [47] Antidepressant Medication Use During Breastfeeding
    di Scalea, Teresa Lanza
    Wisner, Katherine L.
    CLINICAL OBSTETRICS AND GYNECOLOGY, 2009, 52 (03) : 483 - 497
  • [48] Fear of childbirth, mental health, and medication use during pregnancy
    Nordeng, Hedvig
    Hansen, Cathrine
    Garthus-Niegel, Susan
    Eberhard-Gran, Malin
    ARCHIVES OF WOMENS MENTAL HEALTH, 2012, 15 (03) : 203 - 209
  • [49] Psychotropic medication use during pregnancy and gestational age at delivery
    Haviland, Miriam J.
    Nillni, Yael, I
    Fox, Matthew P.
    Savitz, David A.
    Hatch, Elizabeth E.
    Rothman, Kenneth J.
    Hacker, Michele R.
    Wang, Tanran R.
    Wise, Lauren A.
    ANNALS OF EPIDEMIOLOGY, 2021, 53 : 34 - +
  • [50] Primary care physician's attitudes and practices regarding antidepressant use during pregnancy: a survey of two countries
    Bilszta, Justin L. C.
    Tsuchiya, Shauna
    Han, Kwiwon
    Buist, Anne E.
    Einarson, Adrienne
    ARCHIVES OF WOMENS MENTAL HEALTH, 2011, 14 (01) : 71 - 75
12345